missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PDE4D Recombinant Rabbit Monoclonal Antibody (24GB4095)

Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA557155
This item is not returnable.
View return policy
Description
PDE4D Recombinant Monoclonal Antibody for Western Blot, ICC/IF, Flow
This gene encodes one of four mammalian counterparts to the fruit fly 'dunce' gene. The encoded protein has 3',5'-cyclic-AMP phosphodiesterase activity and degrades cAMP, which acts as a signal transduction molecule in multiple cell types. This gene uses different promoters to generate multiple alternatively spliced transcript variants that encode functional proteins.
Specifications
| PDE4D | |
| Recombinant Monoclonal | |
| 0.8 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q08499 | |
| Pde4d | |
| A synthesized peptide derived from human PDE4D (aa 650-809). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Flow Cytometry, Western Blot, Immunocytochemistry | |
| 24GB4095 | |
| Unconjugated | |
| Pde4d | |
| 9630011N22Rik; ACRDYS2; cAMP-specific 3',5'-cyclic phosphodiesterase 4D; cAMP-specific phosphodiesterase 4D; cAMP-specific phosphodiesterase PDE4D; cAMP-specific phosphodiesterase PDE4D6; cAMP-specific phosphodiesterase splice variant PDE4D8; cyclic AMP specific phosphodiesterase PDE4D5A; DKFZp686M11213; Dpde3; dunce; FLJ97311; HGNC:8783; HS PDE4DN2; HSPDE4D; PDE43; Pde4d; PDE4D3; PDE4D7; PDE4DN2; phosphodiesterase 4D; Phosphodiesterase 4D cAMP-specific (dunce; phosphodiesterase 4D, cAMP specific; phosphodiesterase 4D, cAMP-specific; Phosphodiesterase 4D, cAMP-specific (dunce; phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila); STRK1; testicular tissue protein Li 136 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 5144 | |
| -20°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction